Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MURA is expected to report earnings to fall 89.21% to -30 cents per share on November 12
Q3'25
Est.
$-0.30
Q2'25
Missed
by $1.68
Q1'25
Beat
by $0.05
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.10
The last earnings report on August 04 showed earnings per share of -277 cents, missing the estimate of -110 cents. With 296.01K shares outstanding, the current market capitalization sits at 27.55M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MURA showed earnings on August 04, 2025. You can read more about the earnings report here.